ID   FNTA_RAT                Reviewed;         377 AA.
AC   Q04631;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1993, sequence version 1.
DT   02-OCT-2024, entry version 170.
DE   RecName: Full=Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha;
DE            EC=2.5.1.58 {ECO:0000269|PubMed:12657282, ECO:0000269|PubMed:18844669, ECO:0000269|PubMed:19219049, ECO:0000269|PubMed:22963166};
DE            EC=2.5.1.59 {ECO:0000269|PubMed:14609943, ECO:0000269|PubMed:19219049};
DE   AltName: Full=CAAX farnesyltransferase subunit alpha;
DE   AltName: Full=FTase-alpha;
DE   AltName: Full=Ras proteins prenyltransferase subunit alpha;
DE   AltName: Full=Type I protein geranyl-geranyltransferase subunit alpha;
DE            Short=GGTase-I-alpha;
GN   Name=Fnta;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Brain;
RX   PubMed=1763049; DOI=10.1073/pnas.88.24.11368;
RA   Chen W.-J., Andres D.A., Goldstein J.L., Brown M.S.;
RT   "Cloning and expression of a cDNA encoding the alpha subunit of rat p21ras
RT   protein farnesyltransferase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:11368-11372(1991).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS), AND SUBUNIT.
RX   PubMed=9065406; DOI=10.1126/science.275.5307.1800;
RA   Park H.-W., Boduluri S.R., Mooomaw J.F., Casey P.J., Beese L.S.;
RT   "Crystal structure of protein farnesyltransferase at 2.25-A resolution.";
RL   Science 275:1800-1804(1997).
RN   [3]
RP   ERRATUM OF PUBMED:9065406.
RA   Park H.-W., Boduluri S.R., Mooomaw J.F., Casey P.J., Beese L.S.;
RL   Science 276:21-21(1997).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) OF 1-377 IN COMPLEX WITH FNTB, AND
RP   SUBUNIT.
RX   PubMed=9609683; DOI=10.1021/bi980531o;
RA   Dunten P., Kammlott U., Crowther R., Weber D., Palermo R., Birktoft J.;
RT   "Protein farnesyltransferase: structure and implications for substrate
RT   binding.";
RL   Biochemistry 37:7907-7912(1998).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (3.4 ANGSTROMS)IN COMPLEX WITH FNTB, AND SUBUNIT.
RX   PubMed=9657673; DOI=10.1021/bi980708e;
RA   Long S.B., Casey P.J., Beese L.S.;
RT   "Cocrystal structure of protein farnesyltransferase complexed with a
RT   farnesyl diphosphate substrate.";
RL   Biochemistry 37:9612-9618(1998).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 45-377 IN COMPLEX WITH FNTB, AND
RP   SUBUNIT.
RX   PubMed=9843427; DOI=10.1021/bi981197z;
RA   Strickland C.L., Windsor W.T., Syto R., Wang L., Bond R., Wu Z.,
RA   Schwartz J., Le H.V., Beese L.S., Weber P.C.;
RT   "Crystal structure of farnesyl protein transferase complexed with a CaaX
RT   peptide and farnesyl diphosphate analogue.";
RL   Biochemistry 37:16601-16611(1998).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 1-377 IN COMPLEX WITH FNTB, AND
RP   SUBUNIT.
RX   PubMed=10377218; DOI=10.1021/jm990030g;
RA   Strickland C.L., Weber P.C., Windsor W.T., Wu Z., Le H.V., Albanese M.M.,
RA   Alvarez C.S., Cesarz D., del Rosario J., Deskus J., Mallams A.K.,
RA   Njoroge F.G., Piwinski J.J., Remiszewski S., Rossman R.R., Taveras A.G.,
RA   Vibulbhan B., Doll R.J., Girijavallabhan V.M., Ganguly A.K.;
RT   "Tricyclic farnesyl protein transferase inhibitors: crystallographic and
RT   calorimetric studies of structure-activity relationships.";
RL   J. Med. Chem. 42:2125-2135(1999).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 1-377 IN COMPLEX WITH FNTB, AND
RP   SUBUNIT.
RX   PubMed=10673434; DOI=10.1016/s0969-2126(00)00096-4;
RA   Long S.B., Casey P.J., Beese L.S.;
RT   "The basis for K-Ras4B binding specificity to protein farnesyltransferase
RT   revealed by 2 A resolution ternary complex structures.";
RL   Structure 8:209-222(2000).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) IN COMPLEX WITH FNTB, AND SUBUNIT.
RX   PubMed=11687658; DOI=10.1073/pnas.241407898;
RA   Long S.B., Hancock P.J., Kral A.M., Hellinga H.W., Beese L.S.;
RT   "The crystal structure of human protein farnesyltransferase reveals the
RT   basis for inhibition by CaaX tetrapeptides and their mimetics.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:12948-12953(2001).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 1-377 IN COMPLEX WITH FNTB, AND
RP   SUBUNIT.
RX   PubMed=12374986; DOI=10.1038/nature00986;
RA   Long S.B., Casey P.J., Beese L.S.;
RT   "Reaction path of protein farnesyltransferase at atomic resolution.";
RL   Nature 419:645-650(2002).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 1-377 IN COMPLEX WITH FNTB, AND
RP   SUBUNIT.
RX   PubMed=12667062; DOI=10.1021/bi0266838;
RA   Turek-Etienne T.C., Strickland C.L., Distefano M.D.;
RT   "Biochemical and structural studies with prenyl diphosphate analogues
RT   provide insights into isoprenoid recognition by protein farnesyl
RT   transferase.";
RL   Biochemistry 42:3716-3724(2003).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 55-369 IN COMPLEX WITH FNTB,
RP   SUBUNIT, AND CATALYTIC ACTIVITY.
RX   PubMed=12657282; DOI=10.1016/s0960-894x(03)00095-7;
RA   Gwaltney S.L., O'Connor S.J., Nelson L.T., Sullivan G.M., Imade H.,
RA   Wang W., Hasvold L., Li Q., Cohen J., Gu W.Z., Tahir S.K., Bauch J.,
RA   Marsh K., Ng S.C., Frost D.J., Zhang H., Muchmore S., Jakob C.G., Stoll V.,
RA   Hutchins C., Rosenberg S.H., Sham H.L.;
RT   "Aryl tetrahydropyridine inhibitors of farnesyltransferase: glycine,
RT   phenylalanine and histidine derivatives.";
RL   Bioorg. Med. Chem. Lett. 13:1359-1362(2003).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) IN COMPLEX WITH PGGT1B, SUBUNIT,
RP   CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=14609943; DOI=10.1093/emboj/cdg571;
RA   Taylor J.S., Reid T.S., Terry K.L., Casey P.J., Beese L.S.;
RT   "Structure of mammalian protein geranylgeranyltransferase type-I.";
RL   EMBO J. 22:5963-5974(2003).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) IN COMPLEX WITH FNTB, AND SUBUNIT.
RX   PubMed=15170324; DOI=10.1021/bi049723b;
RA   Reid T.S., Beese L.S.;
RT   "Crystal structures of the anticancer clinical candidates R115777
RT   (Tipifarnib) and BMS-214662 complexed with protein farnesyltransferase
RT   suggest a mechanism of FTI selectivity.";
RL   Biochemistry 43:6877-6884(2004).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) IN COMPLEX WITH FNTB, AND SUBUNIT.
RX   PubMed=15451670; DOI=10.1016/j.jmb.2004.08.056;
RA   Reid T.S., Terry K.L., Casey P.J., Beese L.S.;
RT   "Crystallographic analysis of CaaX prenyltransferases complexed with
RT   substrates defines rules of protein substrate selectivity.";
RL   J. Mol. Biol. 343:417-433(2004).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) IN COMPLEX WITH FNTB, SUBUNIT,
RP   CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=18844669; DOI=10.1111/j.1747-0285.2008.00698.x;
RA   DeGraw A.J., Hast M.A., Xu J., Mullen D., Beese L.S., Barany G.,
RA   Distefano M.D.;
RT   "Caged protein prenyltransferase substrates: tools for understanding
RT   protein prenylation.";
RL   Chem. Biol. Drug Des. 72:171-181(2008).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS), SUBUNIT, CATALYTIC ACTIVITY, AND
RP   FUNCTION.
RX   PubMed=19219049; DOI=10.1038/nchembio.149;
RA   Nguyen U.T., Guo Z., Delon C., Wu Y., Deraeve C., Franzel B., Bon R.S.,
RA   Blankenfeldt W., Goody R.S., Waldmann H., Wolters D., Alexandrov K.;
RT   "Analysis of the eukaryotic prenylome by isoprenoid affinity tagging.";
RL   Nat. Chem. Biol. 5:227-235(2009).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) IN COMPLEX WITH FNTB, SUBUNIT,
RP   CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=22963166; DOI=10.1021/jm300624s;
RA   Stigter E.A., Guo Z., Bon R.S., Wu Y.W., Choidas A., Wolf A., Menninger S.,
RA   Waldmann H., Blankenfeldt W., Goody R.S.;
RT   "Development of selective, potent RabGGTase inhibitors.";
RL   J. Med. Chem. 55:8330-8340(2012).
CC   -!- FUNCTION: Essential subunit of both the farnesyltransferase and the
CC       geranylgeranyltransferase complex. Contributes to the transfer of a
CC       farnesyl or geranylgeranyl moiety from farnesyl or geranylgeranyl
CC       diphosphate to a cysteine at the fourth position from the C-terminus of
CC       several proteins having the C-terminal sequence Cys-aliphatic-
CC       aliphatic-X. May positively regulate neuromuscular junction development
CC       downstream of MUSK via its function in RAC1 prenylation and activation.
CC       {ECO:0000269|PubMed:14609943, ECO:0000269|PubMed:18844669,
CC       ECO:0000269|PubMed:19219049, ECO:0000269|PubMed:22963166}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E,6E)-farnesyl diphosphate + L-cysteinyl-[protein] =
CC         diphosphate + S-(2E,6E)-farnesyl-L-cysteinyl-[protein];
CC         Xref=Rhea:RHEA:13345, Rhea:RHEA-COMP:10131, Rhea:RHEA-COMP:11535,
CC         ChEBI:CHEBI:29950, ChEBI:CHEBI:33019, ChEBI:CHEBI:86019,
CC         ChEBI:CHEBI:175763; EC=2.5.1.58;
CC         Evidence={ECO:0000269|PubMed:12657282, ECO:0000269|PubMed:18844669,
CC         ECO:0000269|PubMed:19219049, ECO:0000269|PubMed:22963166};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=geranylgeranyl diphosphate + L-cysteinyl-[protein] =
CC         diphosphate + S-geranylgeranyl-L-cysteinyl-[protein];
CC         Xref=Rhea:RHEA:21240, Rhea:RHEA-COMP:10131, Rhea:RHEA-COMP:11537,
CC         ChEBI:CHEBI:29950, ChEBI:CHEBI:33019, ChEBI:CHEBI:57533,
CC         ChEBI:CHEBI:86021; EC=2.5.1.59;
CC         Evidence={ECO:0000269|PubMed:14609943, ECO:0000269|PubMed:19219049};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P29703};
CC   -!- ACTIVITY REGULATION: Activated by the AGRIN-induced phosphorylation
CC       which is mediated by MUSK. {ECO:0000250|UniProtKB:Q61239}.
CC   -!- SUBUNIT: Heterodimer of FNTA and FNTB (farnesyltransferase)
CC       (PubMed:10377218, PubMed:10673434, PubMed:11687658, PubMed:12374986,
CC       PubMed:12657282, PubMed:12667062, PubMed:15170324, PubMed:15451670,
CC       PubMed:18844669, PubMed:19219049, PubMed:22963166, PubMed:9065406,
CC       PubMed:9609683, PubMed:9657673, PubMed:9843427). Heterodimer of FNTA
CC       and PGGT1B (geranylgeranyltransferase) (PubMed:14609943).
CC       {ECO:0000269|PubMed:10377218, ECO:0000269|PubMed:10673434,
CC       ECO:0000269|PubMed:11687658, ECO:0000269|PubMed:12374986,
CC       ECO:0000269|PubMed:12657282, ECO:0000269|PubMed:12667062,
CC       ECO:0000269|PubMed:14609943, ECO:0000269|PubMed:15170324,
CC       ECO:0000269|PubMed:15451670, ECO:0000269|PubMed:18844669,
CC       ECO:0000269|PubMed:19219049, ECO:0000269|PubMed:22963166,
CC       ECO:0000269|PubMed:9065406, ECO:0000269|PubMed:9609683,
CC       ECO:0000269|PubMed:9657673, ECO:0000269|PubMed:9843427}.
CC   -!- INTERACTION:
CC       Q04631; Q02293: Fntb; NbExp=16; IntAct=EBI-602447, EBI-602454;
CC       Q04631; Q63604: Ntrk2; NbExp=4; IntAct=EBI-602447, EBI-7287667;
CC       Q04631; P53610: Pggt1b; NbExp=7; IntAct=EBI-602447, EBI-602610;
CC       Q04631; P01116-2: KRAS; Xeno; NbExp=3; IntAct=EBI-602447, EBI-367427;
CC   -!- PTM: Phosphorylated. Phosphorylation is mediated by MUSK upon AGRIN
CC       stimulation and results in the activation of FNTA (By similarity).
CC       {ECO:0000250|UniProtKB:Q61239}.
CC   -!- SIMILARITY: Belongs to the protein prenyltransferase subunit alpha
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M81225; AAA41833.1; -; mRNA.
DR   PIR; A41625; A41625.
DR   RefSeq; NP_036979.1; NM_012847.1.
DR   PDB; 1D8D; X-ray; 2.00 A; A=1-377.
DR   PDB; 1D8E; X-ray; 3.00 A; A=1-377.
DR   PDB; 1FPP; X-ray; 2.75 A; A=1-377.
DR   PDB; 1FT1; X-ray; 2.25 A; A=1-377.
DR   PDB; 1FT2; X-ray; 3.40 A; A=55-369.
DR   PDB; 1JCR; X-ray; 2.00 A; A=1-377.
DR   PDB; 1JCS; X-ray; 2.20 A; A=1-377.
DR   PDB; 1KZO; X-ray; 2.20 A; A=1-377.
DR   PDB; 1KZP; X-ray; 2.10 A; A=1-377.
DR   PDB; 1N4P; X-ray; 2.65 A; A/C/E/G/I/K=1-377.
DR   PDB; 1N4Q; X-ray; 2.40 A; A/C/E/G/I/K=1-377.
DR   PDB; 1N4R; X-ray; 2.80 A; A/C/E/G/I/K=1-377.
DR   PDB; 1N4S; X-ray; 2.60 A; A/C/E/G/I/K=1-377.
DR   PDB; 1N94; X-ray; 3.50 A; A=55-369.
DR   PDB; 1N95; X-ray; 2.30 A; A=55-369.
DR   PDB; 1N9A; X-ray; 3.20 A; A=55-369.
DR   PDB; 1NI1; X-ray; 2.30 A; A=55-369.
DR   PDB; 1NL4; X-ray; 2.70 A; A=55-366.
DR   PDB; 1O1R; X-ray; 2.30 A; A=1-377.
DR   PDB; 1O1S; X-ray; 2.30 A; A=1-377.
DR   PDB; 1O1T; X-ray; 2.10 A; A=1-377.
DR   PDB; 1O5M; X-ray; 2.30 A; A=1-377.
DR   PDB; 1QBQ; X-ray; 2.40 A; A=45-377.
DR   PDB; 1S64; X-ray; 2.55 A; A/C/E/G/I/K=1-377.
DR   PDB; 1SA5; X-ray; 2.60 A; A=1-377.
DR   PDB; 1TN7; X-ray; 2.30 A; A=1-377.
DR   PDB; 1TN8; X-ray; 2.25 A; A=1-377.
DR   PDB; 1TNB; X-ray; 2.85 A; A/C/E/G/I/K=1-377.
DR   PDB; 1TNO; X-ray; 2.70 A; A/C/E/G/I/K=1-377.
DR   PDB; 1TNU; X-ray; 2.70 A; A/C/E/G/I/K=1-377.
DR   PDB; 1TNY; X-ray; 2.70 A; A/C/E/G/I/K=1-377.
DR   PDB; 1TNZ; X-ray; 2.90 A; A/C/E/G/I/K=1-377.
DR   PDB; 1X81; X-ray; 3.50 A; A=55-369.
DR   PDB; 2BED; X-ray; 2.70 A; A=54-366.
DR   PDB; 2R2L; X-ray; 2.23 A; A=54-368.
DR   PDB; 2ZIR; X-ray; 2.40 A; A=1-377.
DR   PDB; 2ZIS; X-ray; 2.60 A; A=1-377.
DR   PDB; 3DPY; X-ray; 2.70 A; A=1-377.
DR   PDB; 3E30; X-ray; 2.45 A; A=1-377.
DR   PDB; 3E32; X-ray; 2.45 A; A=1-377.
DR   PDB; 3E33; X-ray; 1.90 A; A=1-377.
DR   PDB; 3E34; X-ray; 2.05 A; A=1-377.
DR   PDB; 3EU5; X-ray; 2.80 A; A=1-377.
DR   PDB; 3EUV; X-ray; 2.75 A; A=1-377.
DR   PDB; 3KSL; X-ray; 2.05 A; A=1-377.
DR   PDB; 3KSQ; X-ray; 2.10 A; A=1-377.
DR   PDB; 3PZ4; X-ray; 2.10 A; A=1-377.
DR   PDB; 4GTM; X-ray; 2.20 A; A=1-377.
DR   PDB; 4GTO; X-ray; 2.15 A; A=1-377.
DR   PDB; 4GTP; X-ray; 2.75 A; A=1-377.
DR   PDB; 4GTQ; X-ray; 2.60 A; A=1-377.
DR   PDB; 4GTR; X-ray; 2.20 A; A=1-377.
DR   PDB; 7RN5; X-ray; 2.28 A; A=1-377.
DR   PDB; 7RNI; X-ray; 1.98 A; A=1-377.
DR   PDB; 8E9E; X-ray; 2.84 A; A=1-377.
DR   PDB; 8RDX; X-ray; 3.67 A; A/C/E/G/I/K=55-368.
DR   PDBsum; 1D8D; -.
DR   PDBsum; 1D8E; -.
DR   PDBsum; 1FPP; -.
DR   PDBsum; 1FT1; -.
DR   PDBsum; 1FT2; -.
DR   PDBsum; 1JCR; -.
DR   PDBsum; 1JCS; -.
DR   PDBsum; 1KZO; -.
DR   PDBsum; 1KZP; -.
DR   PDBsum; 1N4P; -.
DR   PDBsum; 1N4Q; -.
DR   PDBsum; 1N4R; -.
DR   PDBsum; 1N4S; -.
DR   PDBsum; 1N94; -.
DR   PDBsum; 1N95; -.
DR   PDBsum; 1N9A; -.
DR   PDBsum; 1NI1; -.
DR   PDBsum; 1NL4; -.
DR   PDBsum; 1O1R; -.
DR   PDBsum; 1O1S; -.
DR   PDBsum; 1O1T; -.
DR   PDBsum; 1O5M; -.
DR   PDBsum; 1QBQ; -.
DR   PDBsum; 1S64; -.
DR   PDBsum; 1SA5; -.
DR   PDBsum; 1TN7; -.
DR   PDBsum; 1TN8; -.
DR   PDBsum; 1TNB; -.
DR   PDBsum; 1TNO; -.
DR   PDBsum; 1TNU; -.
DR   PDBsum; 1TNY; -.
DR   PDBsum; 1TNZ; -.
DR   PDBsum; 1X81; -.
DR   PDBsum; 2BED; -.
DR   PDBsum; 2R2L; -.
DR   PDBsum; 2ZIR; -.
DR   PDBsum; 2ZIS; -.
DR   PDBsum; 3DPY; -.
DR   PDBsum; 3E30; -.
DR   PDBsum; 3E32; -.
DR   PDBsum; 3E33; -.
DR   PDBsum; 3E34; -.
DR   PDBsum; 3EU5; -.
DR   PDBsum; 3EUV; -.
DR   PDBsum; 3KSL; -.
DR   PDBsum; 3KSQ; -.
DR   PDBsum; 3PZ4; -.
DR   PDBsum; 4GTM; -.
DR   PDBsum; 4GTO; -.
DR   PDBsum; 4GTP; -.
DR   PDBsum; 4GTQ; -.
DR   PDBsum; 4GTR; -.
DR   PDBsum; 7RN5; -.
DR   PDBsum; 7RNI; -.
DR   PDBsum; 8E9E; -.
DR   PDBsum; 8RDX; -.
DR   AlphaFoldDB; Q04631; -.
DR   SMR; Q04631; -.
DR   BioGRID; 247357; 1.
DR   ComplexPortal; CPX-2181; Protein farnesyltransferase complex.
DR   CORUM; Q04631; -.
DR   DIP; DIP-6131N; -.
DR   IntAct; Q04631; 9.
DR   STRING; 10116.ENSRNOP00000019594; -.
DR   BindingDB; Q04631; -.
DR   ChEMBL; CHEMBL2095197; -.
DR   ChEMBL; CHEMBL2111479; -.
DR   iPTMnet; Q04631; -.
DR   PhosphoSitePlus; Q04631; -.
DR   jPOST; Q04631; -.
DR   PaxDb; 10116-ENSRNOP00000019594; -.
DR   GeneID; 25318; -.
DR   KEGG; rno:25318; -.
DR   UCSC; RGD:2625; rat.
DR   AGR; RGD:2625; -.
DR   CTD; 2339; -.
DR   RGD; 2625; Fnta.
DR   eggNOG; KOG0530; Eukaryota.
DR   InParanoid; Q04631; -.
DR   OrthoDB; 20949at2759; -.
DR   PhylomeDB; Q04631; -.
DR   BRENDA; 2.5.1.58; 5301.
DR   BRENDA; 2.5.1.59; 5301.
DR   Reactome; R-RNO-111465; Apoptotic cleavage of cellular proteins.
DR   Reactome; R-RNO-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Reactome; R-RNO-9648002; RAS processing.
DR   SABIO-RK; Q04631; -.
DR   EvolutionaryTrace; Q04631; -.
DR   PRO; PR:Q04631; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005953; C:CAAX-protein geranylgeranyltransferase complex; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005875; C:microtubule associated complex; ISO:RGD.
DR   GO; GO:0005965; C:protein farnesyltransferase complex; ISS:UniProtKB.
DR   GO; GO:0043014; F:alpha-tubulin binding; ISO:RGD.
DR   GO; GO:0004662; F:CAAX-protein geranylgeranyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008017; F:microtubule binding; ISO:RGD.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0004660; F:protein farnesyltransferase activity; IDA:RGD.
DR   GO; GO:0004661; F:protein geranylgeranyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0004663; F:Rab geranylgeranyltransferase activity; ISO:RGD.
DR   GO; GO:0030971; F:receptor tyrosine kinase binding; ISO:RGD.
DR   GO; GO:0007167; P:enzyme-linked receptor protein signaling pathway; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0051771; P:negative regulation of nitric-oxide synthase biosynthetic process; IMP:RGD.
DR   GO; GO:0045787; P:positive regulation of cell cycle; IMP:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; IMP:RGD.
DR   GO; GO:0035022; P:positive regulation of Rac protein signal transduction; ISO:RGD.
DR   GO; GO:1904395; P:positive regulation of skeletal muscle acetylcholine-gated channel clustering; ISO:RGD.
DR   GO; GO:0090044; P:positive regulation of tubulin deacetylation; ISO:RGD.
DR   GO; GO:0018343; P:protein farnesylation; ISS:UniProtKB.
DR   GO; GO:0018344; P:protein geranylgeranylation; ISS:UniProtKB.
DR   GO; GO:0034097; P:response to cytokine; IMP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IMP:RGD.
DR   Gene3D; 1.25.40.120; Protein prenylyltransferase; 1.
DR   InterPro; IPR002088; Prenyl_trans_a.
DR   PANTHER; PTHR11129; PROTEIN FARNESYLTRANSFERASE ALPHA SUBUNIT/RAB GERANYLGERANYL TRANSFERASE ALPHA SUBUNIT; 1.
DR   PANTHER; PTHR11129:SF1; PROTEIN FARNESYLTRANSFERASE_GERANYLGERANYLTRANSFERASE TYPE-1 SUBUNIT ALPHA; 1.
DR   Pfam; PF01239; PPTA; 5.
DR   SUPFAM; SSF48439; Protein prenylyltransferase; 1.
DR   PROSITE; PS51147; PFTA; 5.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Direct protein sequencing; Magnesium;
KW   Prenyltransferase; Reference proteome; Repeat; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P49354"
FT   CHAIN           2..377
FT                   /note="Protein
FT                   farnesyltransferase/geranylgeranyltransferase type-1
FT                   subunit alpha"
FT                   /id="PRO_0000119748"
FT   REPEAT          112..146
FT                   /note="PFTA 1"
FT   REPEAT          147..181
FT                   /note="PFTA 2"
FT   REPEAT          182..214
FT                   /note="PFTA 3"
FT   REPEAT          215..249
FT                   /note="PFTA 4"
FT   REPEAT          255..289
FT                   /note="PFTA 5"
FT   REGION          1..55
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        16..34
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P49354"
FT   STRAND          58..60
FT                   /evidence="ECO:0007829|PDB:1N94"
FT   HELIX           66..68
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   HELIX           70..72
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   STRAND          73..75
FT                   /evidence="ECO:0007829|PDB:2ZIS"
FT   STRAND          87..90
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   HELIX           94..109
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   HELIX           114..126
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   HELIX           131..143
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   HELIX           148..161
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   HELIX           166..179
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   TURN            182..184
FT                   /evidence="ECO:0007829|PDB:1NL4"
FT   HELIX           185..195
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   HELIX           200..213
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   HELIX           216..218
FT                   /evidence="ECO:0007829|PDB:1FPP"
FT   HELIX           219..229
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   TURN            230..232
FT                   /evidence="ECO:0007829|PDB:1N94"
FT   HELIX           234..246
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   STRAND          250..252
FT                   /evidence="ECO:0007829|PDB:7RNI"
FT   HELIX           253..269
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   STRAND          270..272
FT                   /evidence="ECO:0007829|PDB:1N4P"
FT   HELIX           274..284
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   TURN            285..287
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   HELIX           289..291
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   HELIX           293..300
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   HELIX           303..306
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   HELIX           309..324
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   HELIX           330..346
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   TURN            347..349
FT                   /evidence="ECO:0007829|PDB:7RN5"
FT   HELIX           350..352
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   HELIX           353..367
FT                   /evidence="ECO:0007829|PDB:3E33"
FT   TURN            369..372
FT                   /evidence="ECO:0007829|PDB:3E33"
SQ   SEQUENCE   377 AA;  44049 MW;  DFFFECC1B88BC080 CRC64;
     MAATEGVGES APGGEPGQPE QPPPPPPPPP AQQPQEEEMA AEAGEAAASP MDDGFLSLDS
     PTYVLYRDRA EWADIDPVPQ NDGPSPVVQI IYSEKFRDVY DYFRAVLQRD ERSERAFKLT
     RDAIELNAAN YTVWHFRRVL LRSLQKDLQE EMNYIIAIIE EQPKNYQVWH HRRVLVEWLK
     DPSQELEFIA DILNQDAKNY HAWQHRQWVI QEFRLWDNEL QYVDQLLKED VRNNSVWNQR
     HFVISNTTGY SDRAVLEREV QYTLEMIKLV PHNESAWNYL KGILQDRGLS RYPNLLNQLL
     DLQPSHSSPY LIAFLVDIYE DMLENQCDNK EDILNKALEL CEILAKEKDT IRKEYWRYIG
     RSLQSKHSRE SDIPASV
//
